Clinical Trial Update: Efficacy and Safety of Erenumab in Pediatric Participants With Episodic Migraine [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating erenumab for episodic migraine in pediatric participants. The study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• AIMOVIG (ERENUMAB-AOOE)

Snippet

Sponsor: Amgen | Conditions: Migraine | Phase 3 | Status: ACTIVE_NOT_RECRUITING